XTL Biopharmaceuticals Ltd. (TLV:XTLB)
Israel · Delayed Price · Currency is ILS · Price in ILA 2.700
0.00 (0.00%)
At close: Jan 30, 2026
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of 25.55 million as of January 30, 2026. Its market cap has decreased by -67.67% in one year.
Market Cap
25.55M
Enterprise Value
24.97M
Revenue
3.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.70
Market Cap Chart
Since August 30, 2005, XTL Biopharmaceuticals's market cap has decreased from 805.44M to 25.55M, a decrease of -96.83%. That is a compound annual growth rate of -15.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 25.55M | 12.50% |
| Dec 31, 2025 | 22.71M | -72.15% |
| Dec 31, 2024 | 81.53M | 327.50% |
| Dec 31, 2023 | 19.07M | -14.63% |
| Dec 29, 2022 | 22.34M | -52.02% |
| Dec 30, 2021 | 46.56M | -7.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 434.47M |
| Geffen Residence & Renewal | 261.69M |
| Matricelf | 143.84M |
| Clal Biotechnology Industries | 48.47M |
| BioLineRx | 39.16M |
| BioLight Life Sciences | 34.65M |
| Evogene | 27.76M |
| Purple Biotech | 20.44M |